z-logo
open-access-imgOpen Access
Radiation Recall Pneumonitis During Systemic Treatment With Everolimus
Author(s) -
Douglas Clark,
Dron Gauchan,
Ryan Ramaekers,
Max Norvell,
Mehmet Sitki Copur
Publication year - 2015
Publication title -
oncology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.267
H-Index - 57
eISSN - 1555-3906
pISSN - 0965-0407
DOI - 10.3727/096504015x14400775740416
Subject(s) - medicine , radiation therapy , pneumonitis , recall , everolimus , chemotherapy , radiation pneumonitis , oncology , lung , philosophy , linguistics
Radiation recall syndrome is an acute inflammatory reaction developing at anatomical sites of previously irradiated tissue, weeks to months after the completion of radiation therapy. The distribution pattern of inflammation typically involves, and remains limited to, the boundaries of prior radiation treatment fields. Several classical chemotherapy drugs have been reported to have the potential for causing radiation recall syndrome. With the increasing availability and expanding use of novel biologic and targeted therapy anticancer drugs, isolated reports of radiation recall syndrome secondary to this class of agents are starting to appear in the literature. We describe a case of everolimus-induced radiation recall pneumonitis in a patient with metastatic renal cell cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here